Wearing socks does not affect markerless estimation of ankle and foot kinematics

2009 ◽  
Vol 30 ◽  
pp. S52
Author(s):  
E. Surer ◽  
A. Cereatti ◽  
U. Della Croce ◽  
E. Grosso
2006 ◽  
Vol 87 (8) ◽  
pp. 1131-1136 ◽  
Author(s):  
Yu-Chi Huang ◽  
Kimberly Harbst ◽  
Brian Kotajarvi ◽  
Diana Hansen ◽  
Matthew F. Koff ◽  
...  

2006 ◽  
Vol 87 (5) ◽  
pp. 710-716 ◽  
Author(s):  
Yu-Chi Huang ◽  
Kimberly Harbst ◽  
Brian Kotajarvi ◽  
Diana Hansen ◽  
Matthew F. Koff ◽  
...  

2006 ◽  
Vol 87 (1) ◽  
pp. 130-135 ◽  
Author(s):  
Harold B. Kitaoka ◽  
Xavier M. Crevoisier ◽  
Kimberly Harbst ◽  
Diana Hansen ◽  
Brian Kotajarvi ◽  
...  

2021 ◽  
Author(s):  
Gordon Alderink ◽  
Marylee Gowdy ◽  
Joshua Griffith ◽  
Daniel Swanson ◽  
David W.

2009 ◽  
Vol 30 (6) ◽  
pp. 530-539 ◽  
Author(s):  
Jeff R. Houck ◽  
Christopher G. Neville ◽  
Josh Tome ◽  
Adolph S. Flemister

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110251
Author(s):  
Michelle Aaron ◽  
Yu Qing Huang ◽  
Danielle Bouffard ◽  
Jean-Pascal Costa ◽  
Benoît Côté

A 66-year-old woman presented to the hospital with cutaneous necrosis of her right ankle and foot. Her symptoms began immediately after an intra-articular injection of hyaluronic acid for ankle osteoarthritis, which was performed 6 days before. Histopathology showed an intra-vascular hyaluronic acid embolus. The initial treatment approach was conservative, but the patient’s clinical state degraded. She was thus treated with sub-cutaneous hyaluronidase, the enzyme that degrades hyaluronic acid, which yielded a moderate improvement even though it was administered 22 days after the initial hyaluronic acid injection. Although hyaluronic acid embolism and subsequent cutaneous necrosis are well-known complications of dermal fillers, there are few reported cases of embolism following intra-articular injection. To our knowledge, this is the first time hyaluronidase has been used in this setting.


Sign in / Sign up

Export Citation Format

Share Document